Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy · CIDP · CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy) · Sponsor: argenx
The aims of this study are to assess the real-world effectiveness of efgartigimod in treating chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), describe the "treatment journey" of participants with CIDP, and assess the utilization of health care services among adult participants with CIDP who initiate treatment with efgartigimod. As this is a noninterventional study, treatment choices and decisions will be left to the discretion of participants and their physicians, according to the standard of care. Each participant will be prospectively followed for up to 2 years from the date of initial administration of efgartigimod.
This description comes directly from the study's public registry record.
Sabine Coppieters, MD · 857-350-4834 · clinicaltrials@argenx.com
Always discuss trial participation with your own doctor first.
| PPD Virtual | Wilmington, North Carolina, United States | Recruiting |
| Jüdisches Krankenhaus Berlin | Berlin, Germany | Recruiting |
| Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH | Bochum, Germany | Recruiting |
| UK-RUB - Katholisches Klinikum Bochum - St. Josef Hospital | Bochum, Germany | Recruiting |
| Universitätsklinikum Köln | Cologne, Germany | Recruiting |
| Universitätsklinikum Düsseldorf | Düsseldorf, Germany | Recruiting |
| Universitätsklinikum Frankfurt | Frankfurt, Germany | Recruiting |
| UKGM - Universitätsklinikum Gießen und Marburg GmbH | Giessen, Germany | Recruiting |
| Universitätsmedizin Göttingen | Göttingen, Germany | Recruiting |
| Universitätsklinikum Hamburg Eppendorf | Hamburg, Germany | Recruiting |
| Neurologie Neuer Wall - Dr.Bredow & Partner | Hamburg, Germany | Recruiting |
| Medizinische Hochschule Hannover | Hanover, Germany | Recruiting |
+ 11 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07264426